Virtual reality (VR) may be an effective and reliable tool to alleviate the anxiety experienced by most parents or caregivers when their child undergoes surgery, according to research presented at the ANESTHESIOLOGY® 2023 annual meeting.
Teva’s antipsychotic asset passes Phase 3 test in schizophrenia
Teva said Wednesday morning that its schizophrenia drug succeeded in a Phase 3 trial with signs of a differentiated safety profile versus standard of care.
May 9, 2024